ECG Monitoring Systems Market

ECG Monitoring Systems Market, By Equipment Type (ECG Monitoring Equipment, Holter Monitoring Systems, ECG Stress Testing Systems, Event Monitoring Systems), By End User (Hospitals, Ambulatory Surgical Centers, Clinics), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

ECG equipment and management systems are devices that use electromagnetic waves to monitor heartbeats, which can then be displayed on an ECG panel. ECG equipment and management systems are being used to diagnose various cardiovascular and coronary diseases in patient, allowing for the most appropriate medical care. The ECG test is a safe, effective, and painless tool for determining cardiac discrepancy patterns. ECG devices determine how the heart is functioning in the body as it is subjected to some stimuli or activities. Incessant illness has become a significant cause of illnesses and diseases all over the globe, putting a lot of emphasis on the healthcare sector to follow a modern paradigm of medical evaluation and improved medical services, raising investment in new inventions in ECG equipment and management systems.

Market Dynamics

Cardiac monitoring is one of the most reliable and efficient options for monitoring various cardiac conditions. Various advancements, product approvals and launches, partnerships, and acquisitions by the key market players in cardiac monitoring devices are likely to boost the growth of the studied market over the forecast period. For instance, in August 2022, Merit Medical Systems, Inc. is a manufacturer and marketer of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures in U.S., launched the SafeGuard Focus Cool Compression Device, an innovative addition to its SafeGuard platform. It is a component of a more extensive cardiac portfolio that also includes the tools and accessories required for interventional cardiac resynchronization therapy, electrophysiology, and management of cardiac rhythm. Moreover, in February 2022, Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States, launched one of the first patient implants of a dual-chamber leadless pacemaker system as part of its AVEIR DR i2i pivotal clinical study. The implant of Abbott's investigational Aveir dual-chamber leadless pacemaker took place globally within the crucial study and marks a significant technological milestone for leadless pacing technology. Also, in November 2020, VitalConnect, Inc., a developer of remote and in-hospital wearable biosensor technology, launched its VitalPatch RTM cardiac monitoring solution. VitalPatch RTM monitors for 21 cardiac arrhythmias through a unique Artificial Intelegnce-based ECG analysis solution and captures data on four key vital signs, providing a thorough understanding of a patient's state.

Key features of the study:

• This report provides an in-depth analysis of the global ECG monitoring systems market and provides market size (US$ Million) and compound annual growth rate (CAGR) for the forecast period (2023–2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global ECG monitoring systems market based on the following parameters– company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include GE Healthcare, Philips Healthcare, Nihon Kohden, Schiller AG, Opto Circuits (India) Limited, Welch Allyn, Fukuda Denshi Co., Ltd., OSI Systems, Lidco Group plc, Biotricity Inc., Bittium Corporation,Lupin Ltd., St. Jude Medical Inc., VivaQuant, and Johnson & Johnson
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding its future product launches, type up-gradation, market expansion, and marketing tactic
• The global ECG monitoring systems market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global ECG monitoring systems market

Detailed Segmentation:

• Global ECG Monitoring Systems Market, By Equipment Type:
• ECG Monitoring Equipment
• Holter Monitoring Systems
• ECG Stress Testing Systems
• Event Monitoring Systems
• Global ECG Monitoring Systems Market, By End User:
• Hospitals,
• Ambulatory
• Surgical Centers
• Clinics
• Global ECG Monitoring Systems Market, By Region:
• North America
• U.S.
• Canada
• Latin America
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
• Germany
• U.K.
• France
• Italy
• Spain
• Russia
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
• GCC
• Israel
• Rest of Middle East
• Africa
• South Africa
• Central Africa
• North Africa
• Company Profiles
• GE Healthcare
• Philips Healthcare
• Nihon Kohden
• Schiller AG
• Opto Circuits (India) Limited
• Welch Allyn
• Fukuda Denshi Co., Ltd.
• OSI Systems
• Lidco Group plc
• Biotricity Inc.
• Bittium Corporation
• Jude Medical Inc.
• VivaQuant
• Johnson & Johnson
• Lupin Ltd.